General form of registration statement for all companies including face-amount certificate companies

Stock-based compensation (Tables)

v2.4.1.9
Stock-based compensation (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2015
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]    
Schedule of Total Stock-Based Compensation Expense Related to Share-Based Awards under the Pieris Plan

Total stock-based compensation expense, related to all share-based awards under the Pieris Plan to executive officers, directors, employees and consultants recognized for the three months ended March 31, 2015, was comprised of the following:

 

     Three months ended
March 31, 2015
 

Research and Development

   $ 51,038   

General and administrative

     166,297   
  

 

 

 

Total stock-option expense

$         217,335   
  

 

 

Total stock-based compensation expense, related to all share-based awards under the Pieris Plan to executive officers, directors, employees and consultants recognized during the year ended 2014, was comprised of the following:

 

     December 31, 2014  

Research and Development

   $ 7,623   

General and administrative

     563,759   
  

 

 

 

Total stock-option expense

$ 571,382   
  

 

 

Schedule of Weighted-Average Assumptions Used for Calculating Value of Options Granted

The fair value of option grants was estimated using the Black-Scholes model. The following table describes the weighted-average assumptions used for calculating the value of options granted for the three months ended March 31, 2015:

 

     Three months ended
March 31, 2015
 

Dividend yield

     0.0

Expected volatility

     75.1

Weighted average risk-free interest rate

     1.66

Expected term

     5.8 years   

The fair value of option grants was estimated using the Black-Scholes model. The following table describes the weighted-average assumptions used for calculating the value of options granted for the year ended December 31, 2014:

 

     2014  

Dividend yield

     0.0

Expected volatility

     74.66

Weighted average risk-free interest rate

     1.77

Expected term

     5.6-5.8 years   
Schedule of Information Regarding Stock Option Activity

A summary of the Company´s stock option activity and related information is as follows:

 

     Number of
shares
    Weighted-
Average
Exercise
Price
    Weighted-
Average
Contractual
Life
 

Outstanding at December 31, 2014

     2,519,500      $ 2.00        5.6-5.8 years   

Options granted

     25,000      $ 2.85        5.8 years   

Options exercised

                   

Options canceled or expired

                   

Outstanding at March 31, 2015

     2,544,500      $ 2.01        5.6-5.8 years   

Vested or expected to vest at March 31, 2015

     598,396      $ 2.00         

Exercisable at March 31, 2015

     598,396      $ 2.00         

A summary of the Company’s stock option activity and related information is as follows:

 

     Number of
shares
    Weighted-Average
Exercise Price
    Weighted-Average
Contractual Life
 

Outstanding at December 31, 2013

         $        

Options granted

     2,519,500      $ 2.00        5.6-5.8 years   

Options exercised

                  

Options canceled or expired

                  

Outstanding at December 31, 2014

     2,519,500      $ 2.00        5.6-5.8 years   

Vested or expected to vest at December 31, 2014

     423,750      $ 2.00         

Exercisable at December 31, 2014

         $